A 6-wk Open-Label, Randomised, Multicentre, Phase IIIb, Parallel-group Study, which describes the Renal effects of the Lipid-Regulating Agents Rosuvastatin and Simvastatin in the treatment of sub's with Fredrickson Type IIa and Type IIb Dyslipidaemia, inc. Heterozygous Familial Hypercholesterolaemia

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].